Jump to terms for: MedTech Innovator Asia Pacific, BioTools Innovator
MedTech Innovator Terms & Conditions
PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY. THESE TERMS AND CONDITIONS ALSO SERVE AS CONTEST RULES FOR THE MEDTECH INNOVATOR PROGRAM 2024. BY SUBMITTING AN APPLICATION, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS BELOW. THESE TERMS AND CONDITIONS ARE SUBJECT TO CHANGE WITHOUT NOTICE, FROM TIME TO TIME IN OUR SOLE DISCRETION. WE WILL NOTIFY YOU OF AMENDMENTS TO THESE TERMS AND CONDITIONS BY POSTING THEM TO THIS WEBSITE.
MedTech Innovator began accepting applications for the 2024 program on November 13, 2023. The program for 2024 includes multiple rounds of the competition in which participants receive additional levels of benefits as they advance:
- Applications will be evaluated, and companies identified as being of strategic interest to the selection committee will be invited to pitch in-person or online
- A minimum of 50 companies will be selected to join the Accelerator program, which will start on June 1, 2024 and end mid-November, 2024
- MedTech Innovator’s 2024 program will include a three-day Summit, including a showcase and participation at the Wilson Sonsini Medical Device and Digital Health Conference on June 14 in San Francisco / Bay Area
- MedTech Innovator’s 2024 program will culminate with company presentations in the MedTech Innovator Showcase at The MedTech Conference powered by AdvaMed in Toronto, Canada on October 15-17
- Up to five of the Early-Stage Accelerator companies will be selected to present in the finals competition session at The MedTech Conference powered by Advamed on October 16, 2024, and the winner will be selected by an audience vote
- Up to five of the Mid-Stage Accelerator companies will be selected to present in the Mid-Stage finals competition session at The MedTech Strategist San Francisco, 2024 and the winner will be selected by an audience vote
Prizes
The MedTech Innovator 2024 program will include cash prizes of at least $700,000 (US$). Prizes for MedTech Innovator 2024 are gifts, with no equity, dilution or similar “strings attached”. Eligibility for further participation and prizes is subject to execution of an Affidavit of Eligibility, Publicity Release, and Liability Waiver.
No equity or application fees
MedTech Innovator is a non-profit with a mission to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. There are no application fees, and companies do not give equity to MedTech Innovator or its partners in exchange for participation. To be awarded any benefits or other prizes, companies will be required to sign an Affidavit of Eligibility, Publicity Release, and Liability Waiver.
Eligibility Requirements
All early to mid-stage medtech (medical device, diagnostic, or digital health) companies are eligible to apply. Companies will be evaluated on a variety of criteria including, but not limited to, their management teams, control or access to owned, licensed or protectable IP/technology, development plans, ability to demonstrate a customer-validated market need, and the potential to improve value for healthcare. Companies of all stages are eligible for the Accelerator program.
Intellectual Property
All competition participants will be responsible for taking the proper steps to protect their intellectual property. You agree to submit only non-confidential materials in connection with your application and in connection with any of the presentations, pitches, or other programs that are a part of MedTech Innovator 2024. We will attempt to contact any company submitting materials marked “Confidential” and request appropriate replacement materials without confidentiality markings, but we are not responsible for the confidentiality of any of your materials. The competition process is a public event, from the application process through to the onstage competitions. Judges, organizers, sponsors, reviewers, and other individuals involved do not sign non-disclosure agreements.
The ownership of the technology must be identified. Teams will not be permitted to present ideas based on science and technology owned by third parties who have not licensed their technology to the presenting company (or in the case where negotiations are ongoing, expressed a clear intent to license the technology to the participants, pending agreement on terms). The organizers of the competition may disqualify any team failing to comply with this rule and shall be held harmless due to such action.
Process, Timeline, and Deadlines
Time period for submission of unsolicited applications begins on November 13, 2023 at 12:00 AM ET and ends on January 31, 2024 at 11:59 PM ET. The application is available at https://medtechinnovator.org/apply. Applicants will enter a very competitive process. During the months of February through May, highly-scored applicants may be invited to pitch to a panel of judges in-person or online. After the pitch, participants selected to advance to compete for a slot in the accelerator will be required to submit additional information, including 1-minute videos. In May, a minimum of fifty participants will be selected as Accelerator companies and gain entry to the virtual accelerator. From June through November, Accelerator companies will participate in virtual and in-person events where industry stakeholders will mentor them. Accelerator companies will receive complimentary registration for these in-person events, including the Wilson Sonsini Medical Device and Digital Health conference in San Francisco and The MedTech Conference powered by AdvaMed in Anaheim. During the Accelerator program, the selection process will continue, and up to five Early-Stage Accelerator companies will be selected as Finalists to compete on-stage during The MedTech Conference powered by AdvaMed for the prizes which will be awarded by an audience vote. The final deadline for unsolicited online applications is 11:59 PM ET January 31, 2024 for the 2024 competition. Applications may also be accepted during the months of February through April for consideration that are referred by entities affiliated with MedTech Innovator or directly invited by MedTech Innovator. Applications are open to companies that meet the eligibility criteria listed on the 2024 competition Apply page at https://medtechinnovator.org/apply.
Audience will use their internet or mobile connected devices to vote for the pitch that they think should be the winner. If there is a tie, then a run-off vote will be taken. In the event of a second tie, then the prize will be split between the tying companies.
The winner will be announced in a subsequent press release. Prizes will be distributed within 90 days of the end of the competition.
Applicants invited to advance to the pitch events will be notified by email on a rolling basis from February through April 2024. Event attendees may be photographed or videotaped for use in MedTech Innovator promotional materials. The Accelerator companies will be notified by email by mid-May 2024.
Companies advancing to the 2023 Accelerator program will be required to make a 1-minute video. Deadline for submission of videos for the Showcase will be September 13, 2024.
By submitting an application to MedTech Innovator and/or by attending a MedTech Innovator event, you will automatically be added to the MedTech Innovator mailing list. Your contact information may also be made available to event attendees and/or MedTech Innovator sponsors through our BioBook. Should you wish to opt-out, please contact MedTech Innovator to indicate your desire to be removed from the attendee list or select the unsubscribe option on any email.
Any and all questions should be made electronically to support@medtechinnovator.org.
Key Milestones for 2024
- November 13, 2023 Online Applications Open
- January 31, 2024 Online Applications Close
- February – May 2024 MedTech Innovator Road Tour (Online & In-Person Pitch Events)
- June 12-13, 2024 MedTech Innovator Summit in San Francisco / Bay Area
- June – October 2024 MedTech Innovator Virtual Accelerator Program
- October 15-17, 2024 MedTech Innovator Showcase & Finals at The MedTech Conference powered by AdvaMed in Toronto, Canada
MedTech Innovator Asia Pacific Terms & Conditions
PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY. THESE TERMS AND CONDITIONS ALSO SERVE AS CONTEST RULES FOR MEDTECH INNOVATOR ASIA PACIFIC 2024. BY SUBMITTING AN APPLICATION, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS BELOW. THESE TERMS AND CONDITIONS ARE SUBJECT TO CHANGE WITHOUT NOTICE, FROM TIME TO TIME IN OUR SOLE DISCRETION. WE WILL NOTIFY YOU OF AMENDMENTS TO THESE TERMS AND CONDITIONS BY POSTING THEM TO THIS WEBSITE.
MedTech Innovator Asia Pacific began accepting applications for the 2023 program on November 13, 2023. The program for 2024 includes multiple rounds of the competition in which participants receive additional levels of benefits as they advance:
- Applications will be evaluated, and companies identified as being of strategic interest to the selection committee will be invited to pitch in-person or online
- Up to 25 “Accelerator” companies will be selected to join in a virtual Accelerator program, which will start on June 1, 2024 and end on September 30, 2024
- These Accelerator companies will present in the MedTech Innovator Asia Pacific Showcase at The MedTech Forum in Singapore (September 5 and 6, 2024) and will each receive one complimentary full-access registration to the conference
- Up to five of the Accelerator companies will be selected to present in the finals competition session at The MedTech Forum on (September 5 and 6, 2024) and the winner will be selected by an audience vote
Prizes
The MedTech Innovator Asia Pacific 2024 program will include cash prizes of at least $150,000 (USD) as well as conference scholarships and in-kind awards. Prizes for MedTech Innovator 2024 are gifts, with no equity, dilution or similar “strings attached”. Eligibility for further participation and prizes is subject to execution of an Affidavit of Eligibility, Publicity Release, and Liability Waiver.
No Equity or Application Fees
MedTech Innovator is a non-profit with a mission to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. There are no application fees, and companies do not give equity to MedTech Innovator or its partners in exchange for participation. To be awarded any benefits or other prizes, companies will be required to sign an Affidavit of Eligibility, Publicity Release, and Liability Waiver.
Eligibility Requirements
All early- to mid-stage medtech (medical device, diagnostic, or digital health) companies are eligible to apply. Companies will be evaluated on a variety of criteria including, but not limited to, their management teams; control or access to owned, licensed or protectable IP/technology; development plans; ability to demonstrate a customer-validated market need; and the potential to improve value for healthcare. Companies of all stages are eligible for the Accelerator program.
Intellectual Property
All competition participants will be responsible for taking the proper steps to protect their intellectual property. You agree to submit only non-confidential materials in connection with your application and in connection with any of the presentations, pitches, or other programs that are a part of MedTech Innovator Asia Pacific 2024. We will attempt to contact any company submitting materials marked “Confidential” and request appropriate replacement materials without confidentiality markings, but we are not responsible for the confidentiality of any of your materials. The competition process is a public event, from the application process through to the onstage competitions. Judges, organizers, sponsors, reviewers, and other individuals involved do not sign non-disclosure agreements.
The ownership of the technology must be identified. Teams will not be permitted to present ideas based on science and technology owned by third parties who have not licensed their technology to the presenting company (or in the case where negotiations are ongoing, expressed a clear intent to license the technology to the participants, pending agreement on terms). The organizers of the competition may disqualify any team failing to comply with this rule and shall be held harmless due to such action.
Process, Timeline, and Deadlines
Time period for submission of unsolicited applications begins on November 13, 2023 at 12:00 AM ET and ends on January 31, 2024 at 11:59 PM ET. The application is available at https://medtechinnovator.org/asia-pacific/. Applicants will enter a very competitive process. During the months of February through May, highly-scored applicants may be invited to pitch to a panel of judges in-person or online. After the in-person pitch, participants selected to advance to compete for a space in the accelerator will be required to submit additional information, including 1-minute videos. In May, up to twenty-five participants will be selected as Accelerator companies and gain entry to the virtual accelerator. From June through September, Accelerator companies will participate in virtual events where industry stakeholders will mentor them. Accelerator companies will receive complimentary registration for The MedTech Forum in Singapore. During the Accelerator program, the selection process will continue, and up to five Accelerator companies will be selected as Finalists to compete on-stage during The MedTech Forum for the prizes, which will be awarded by an audience vote. The final deadline for unsolicited online applications is 11:59 PM ET January 31 for the 2024 competition. Applications may also be accepted during the months of February through April for consideration that are referred by entities affiliated with MedTech Innovator Asia Pacific or directly invited by MedTech Innovator. Applications are open to companies that meet the eligibility criteria listed on the 2023 competition Apply page at https://medtechinnovator.org/asia-pacific/.
Audience will use their mobile connected devices to vote for the pitch that they think should be the winner. If there is a tie, then a run-off vote will be taken. In the event of a second tie, then the prize will be split between the tying companies.
The winner will be announced in a subsequent press release. Prizes will be distributed within 90 days of the end of the competition.
Applicants invited to advance to the pitch events will be notified by email on a rolling basis from February through April 2024. Event attendees may be photographed or videotaped for use in MedTech Innovator Asia Pacific promotional materials. The Accelerator companies will be notified by email by May 31, 2024.
Companies advancing to the 2023 Accelerator program will be required to make a 1-minute video. Deadline for submission of videos for the Accelerator TBA (approx. August 2024).
By submitting an application to MedTech Innovator Asia Pacific and/or by attending a MedTech Innovator Asia Pacific event, you will automatically be added to the MedTech Innovator mailing list. Your contact information may also be made available to event attendees and/or MedTech Innovator sponsors through our BioBook. Should you wish to opt-out, please contact MedTech Innovator to indicate your desire to be removed from the attendee list or select the unsubscribe option on any email.
Any and all questions should be made electronically to apacsupport@medtechinnovator.org.
Key Milestones for 2024
- November 13, 2023 Online Applications Open
- January 31, 2024 Online Applications Close
- February – May 2024 MedTech Innovator Road Tour (Online / In-Person Pitch Events)
- June – September 2024 MedTech Innovator Virtual Program (Accelerator & Showcase)
- September 2024 MedTech Innovator Asia Pacific Showcase & Finals Competition at The MedTech Forum in Singapore
BioTools Innovator 2023 Terms & Conditions
PLEASE READ THESE TERMS AND CONDITIONS CAREFULLY. THESE TERMS AND CONDITIONS ALSO SERVE AS CONTEST RULES FOR BIOTOOLS INNOVATOR 2024, POWERED BY MEDTECH INNOVATOR. BY SUBMITTING AN APPLICATION, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS BELOW. THESE TERMS AND CONDITIONS ARE SUBJECT TO CHANGE WITHOUT NOTICE, FROM TIME TO TIME IN OUR SOLE DISCRETION. WE WILL NOTIFY YOU OF AMENDMENTS TO THESE TERMS AND CONDITIONS BY POSTING THEM TO THIS WEBSITE.
MedTech Innovator began accepting applications for the BioTools Innovator 2023 program on January 31, 2024. The program for 2024 includes multiple rounds of the competition in which participants receive additional levels of benefits as they advance:
- Applications will be evaluated, and companies identified as being of strategic interest to the selection committee will be invited to pitch in-person or online
- Up to 20 “Accelerator” companies will be selected to join in a virtual Accelerator program, which will start on June 1, 2024 and end on October 31, 2024
- BioTools Innovator 2023 program will culminate with the BioTools Innovator Capstone Event which includes company presentations and the Finals Competition. This event will tentatively take place in September/October 2024
- Up to five of the Accelerator companies will be selected to present in the finals competition, which will tentatively take place in September/October 2024 and the winner will be selected by an audience vote
Prizes
The BioTools Innovator 2024 program will include cash prizes of at least $250,000 (US$). Prizes for BioTools Innovator 2024 are gifts, with no equity, dilution or similar “strings attached”. Eligibility for further participation and prizes is subject to execution of an Affidavit of Eligibility, Publicity Release, and Liability Waiver.
No equity or application fees
MedTech Innovator is a non-profit with a mission to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. There are no application fees, and companies do not give equity to MedTech Innovator or its partners in exchange for participation. To be awarded any benefits or other prizes, companies will be required to sign an Affidavit of Eligibility, Publicity Release, and Liability Waiver.
Eligibility Requirements
All early stage life science tools & diagnostics companies are eligible to apply. Companies will be evaluated on a variety of criteria including, but not limited to, their management teams, control or access to owned, licensed or protectable IP/technology, development plans, ability to demonstrate a customer-validated market need, and the potential to improve human health. Companies that have raised a Series A round or earlier are eligible for the Accelerator program.
Intellectual Property
All competition participants will be responsible for taking the proper steps to protect their intellectual property. You agree to submit only non-confidential materials in connection with your application and in connection with any of the presentations, pitches, or other programs that are a part of BioTools Innovator 2024. We will attempt to contact any company submitting materials marked “Confidential” and request appropriate replacement materials without confidentiality markings, but we are not responsible for the confidentiality of any of your materials. The competition process is a public event, from the application process through to the onstage competitions. Judges, organizers, sponsors, reviewers, and other individuals involved do not sign non-disclosure agreements.
The ownership of the technology must be identified. Teams will not be permitted to present ideas based on science and technology owned by third parties who have not licensed their technology to the presenting company (or in the case where negotiations are ongoing, expressed a clear intent to license the technology to the participants, pending agreement on terms). The organizers of the competition may disqualify any team failing to comply with this rule and shall be held harmless due to such action.
Process, Timeline, and Deadlines
Time period for submission of unsolicited applications begins on November 13, 2023 at 12:00 AM ET and ends on January 31, 2024 at 11:59 PM ET. The application is available at http://biotoolsinnovator.org/. Applicants will enter a very competitive process. During the months of March through May, highly-scored applicants may be invited to pitch to a panel of judges in-person or online. After the pitch, participants selected to advance to compete for a slot in the accelerator will be required to submit additional information, including 1-minute videos. In June, up to fifteen participants will be selected as Accelerator companies and gain entry to the virtual accelerator. From June through October, Accelerator companies will participate in virtual and in-person events where industry stakeholders will mentor them. During the Accelerator program, the selection process will continue, and up to five Accelerator companies will be selected as Finalists to compete on-stage during the Finals Competition for the prizes which will be awarded by an audience vote. The final deadline for unsolicited online applications is 11:59 PM ET January 31, 2024 for the 2023 competition. Applications may also be accepted during the months of February through April for consideration that are referred by entities affiliated with MedTech Innovator or directly invited by MedTech Innovator. Applications are open to companies that meet the eligibility criteria listed on the 2024 competition. Apply page at http://biotoolsinnovator.org/.
Audience will use their internet or mobile connected devices to vote for the pitch that they think should be the winner. If there is a tie, then a run-off vote will be taken. In the event of a second tie, then the prize will be split between the tying companies.
The winner will be announced in a subsequent press release. Prizes will be distributed within 90 days of the end of the competition.
Applicants invited to advance to the pitch events will be notified by email on a rolling basis from February through April 2023. Event attendees may be photographed or videotaped for use in MedTech Innovator promotional materials. The Accelerator companies will be notified by email by end of May 2023.
Companies advancing to the Accelerator program will be required to make a 1-minute video. Deadline for submission of videos will be September 13, 2024.
By submitting an application to BioTools Innovator and/or by attending a BioTools Innovator event, you will automatically be added to the BioTools Innovator mailing list. Your contact information may also be made available to event attendees and/or MedTech Innovator sponsors through our BioBook. Should you wish to opt-out, please contact MedTech Innovator to indicate your desire to be removed from the attendee list or select the unsubscribe option on any email.
Any and all questions should be made electronically to support@medtechinnovator.org.
Key Milestones for 2024
- November 13, 2023 Online Applications Open
- January 31, 2024 Online Applications Close
- March through May 2024 BioTools Innovator Road Tour (Online / In-Person Pitch Events)
- June 12-13, 2023 MedTech Innovator Summit in San Francisco / Bay Area
- June through September-October 2024 BioTools Innovator Accelerator Program
- September-October 2024 BioTools Innovator Capstone Event & Finals